QUININE
The current Australian Poisons Standard places this cosmetic or personal-care use in Schedule 6.
규제 판단 및 전체 조건
- 상태
- Restricted
- 법적 역할
- Binding rule
- 규제 요약
- The current Australian Poisons Standard places this cosmetic or personal-care use in Schedule 6.
- 조건 및 제한 사항
QUININE in cosmetic preparations except: (a) in rinse-off hair preparations containing 0.5% or less of quinine calculated as free base; or (b) in leave-on hair preparations containing 0.2% or less of quinine calculated as free base.
물질 정체
- 공식 출처상의 명칭
- QUININE
- CAS
- 130-95-0
- EC
- 205-003-2
- 정체 매핑
- exact_name
- 연결된 원료
- QUININE
연결된 CosIng 정체 데이터
명칭 및 별칭
CosIng 설명: Cinchonan-9-ol, 6'-methoxy-, (8.alpha., 9R)-
EU 목록 제한 사항 주석: III/21
기록된 화장품 기능: DENATURANT, FRAGRANCE, HAIR CONDITIONING
기능 페이지:DENATURANT, FRAGRANCE, HAIR CONDITIONING
전체 원료 프로필 보기이 정체의 시장 간 요약
현재 이 사이트에 있는 정확히 연결된 기록입니다. 시장이 없는 것은 가져온 정확한 일치 항목이 없다는 뜻이며, 해당 물질의 사용이 허용된다는 뜻이 아닙니다.
European Union
연결된 기록 1건 · 특정 조건이 있는 기록 1건
보조 기록 열기Great Britain
연결된 기록 1건 · 특정 조건이 있는 기록 1건
보조 기록 열기New Zealand
연결된 기록 1건 · 특정 조건이 있는 기록 1건
보조 기록 열기ASEAN
연결된 기록 1건 · 특정 조건이 있는 기록 1건
보조 기록 열기South Korea
연결된 기록 1건 · 특정 조건이 있는 기록 1건
보조 기록 열기Australia
현재 기록연결된 기록 1건 · 특정 조건이 있는 기록 1건
보조 기록 열기India
연결된 기록 1건 · 특정 조건이 있는 기록 1건
보조 기록 열기Saudi Arabia
연결된 기록 1건
보조 기록 열기
CAS 130-95-0의 검증된 화학 정보
Quinine
Quinine is a cinchona alkaloid that is cinchonidine in which the hydrogen at the 6-position of the quinoline ring is substituted by methoxy. It has a role as a non-narcotic analgesic, an antimalarial and a muscle relaxant. It is a conjugate base of a quinine(1+). It derives from a hydride of an (8S)-cinchonan. — ChEBI
- IUPAC 명칭
- (R)-[(2S,4S,5R)-5-ethenyl-1-azabicyclo[2.2.2]octan-2-yl]-(6-methoxyquinolin-4-yl)methanol
- 분자식
- C20H24N2O2
- 분자량
- 324.4 g/mol
- 정확한 질량
- 324.183778013 Da
- 단일 동위원소 질량
- 324.183778013 Da
- XLogP3
- 2.9
- 위상 극성 표면적
- 45.6 Ų
- 분자 복잡도
- 457.0
- 형식 전하
- 0
- 수소 결합 공여체
- 1
- 수소 결합 수용체
- 4
- 회전 가능 결합
- 4
- 중원자
- 24
- 공유결합 단위
- 1
PubChem에 보고된 명칭 및 동의어
보고된 명칭 16개 더 보기
외부 데이터베이스 식별자
고급 구조 통계
- 정의된 원자 입체중심
- 4
- 정의되지 않은 원자 입체중심
- 0
- 정의된 결합 입체중심
- 0
- 정의되지 않은 결합 입체중심
- 0
- 3D 파마코포어 특성
- 9
- 3D 고리
- 3
- 3D 소수성 부위
- 1
- 3D 수용체 특성
- 3
- 3D 공여체 특성
- 1
- 3D 음이온 중심
- 0
- 3D 양이온 중심
- 1
- 3D 형태이성질체
- 7
- 유효 3D 회전자
- 5.2
기계 판독 가능한 구조 식별자
- SMILES
COC1=CC2=C(C=CN=C2C=C1)[C@H]([C@@H]3C[C@@H]4CCN3C[C@@H]4C=C)O- InChI
InChI=1S/C20H24N2O2/c1-3-13-12-22-9-7-14(13)10-19(22)20(23)16-6-8-21-18-5-4-15(24-2)11-17(16)18/h3-6,8,11,13-14,19-20,23H,1,7,9-10,12H2,2H3/t13-,14-,19-,20+/m0/s1- InChIKey
LOUPRKONTZGTKE-WZBLMQSHSA-N
추가 과학 데이터베이스의 근거
NIH PubChem PUG-View
Attributed physical-property, hazard, environmental and use annotations.
- Color/Form: Triboluminescent, orthorhombic needles from absolute alcohol 출처: Hazardous Substances Data Bank (HSDB)
- Color/Form: Bulky, white, amorphous powder or crystalline alkaloid 출처: Hazardous Substances Data Bank (HSDB)
- Color/Form: CRYSTALS TURN BROWN ON EXPOSURE TO AIR 출처: Hazardous Substances Data Bank (HSDB)
- Basic pKa: 8.56 출처: ChEMBL
- Basic pKa: 8.55 출처: ChEMBL
- Dissociation Constants: pK1 (18 °C) = 5.07; pK2 = 9.7 출처: Hazardous Substances Data Bank (HSDB)
- LogP: 3.44 출처: DrugBank
- LogP: log Kow = 3.44 출처: Hazardous Substances Data Bank (HSDB)
- LogP: 2.6 출처: Human Metabolome Database (HMDB)
- Melting Point: 57 °C 출처: DrugBank
- Melting Point: 177 °C (some decomposition) 출처: Hazardous Substances Data Bank (HSDB)
- Melting Point: Microcrystalline powder; mp: 57 °C; efflorescent; loses one water molecule in air, two water molecules over sulfuric acid; anhydrous at 125 °C /Quinine trihydrate/ 출처: Hazardous Substances Data Bank (HSDB)
- Melting Point: 57 °C 출처: Human Metabolome Database (HMDB)
- Odor: ODORLESS 출처: Hazardous Substances Data Bank (HSDB)
- Physical Description: Solid 출처: Human Metabolome Database (HMDB)
- Refractive Index: INDEX OF REFRACTION: 1.625 출처: Hazardous Substances Data Bank (HSDB)
- Solubility: 500 mg/L (at 15 °C) 출처: DrugBank
- Solubility: In water, 500 mg/L at 15 °C 출처: Hazardous Substances Data Bank (HSDB)
- Solubility: 1 g dissolves in: 1900 mL water, 760 mL boiling water 출처: Hazardous Substances Data Bank (HSDB)
- Solubility: 1 g dissolves in: 80 mL benzene (18 mL at 50 °C), 1.2 mL chloroform, 250 mL dry ether, 20 mL glycerol, 0.8 mL alcohol, 1900 mL of 10% ammonia water; almost insoluble in petroleum ether 출처: Hazardous Substances Data Bank (HSDB)
- Solubility: Soluble in ether, chloroform, carbon disulfide, glycerol, alkalies, and acids (with formation of salts) 출처: Hazardous Substances Data Bank (HSDB)
- Solubility: Sol in pyrimidine 출처: Hazardous Substances Data Bank (HSDB)
- Solubility: 3.34e-01 g/L 출처: Human Metabolome Database (HMDB)
- pH: pH of saturated aqueous solution = 8.8 출처: Hazardous Substances Data Bank (HSDB)
- Carcinogen Classification: No indication of carcinogenicity to humans (not listed by IARC). 출처: Toxin and Toxin Target Database (T3DB)
- Exposure Routes: Oral 출처: Toxin and Toxin Target Database (T3DB)
- Signal: Danger 출처: European Chemicals Agency (ECHA)
- GHS Hazard Statements: H302 (22.9%): Harmful if swallowed [Warning Acute toxicity, oral]; H315 (28.4%): Causes skin irritation [Warning Skin corrosion/irritation]; H317 (99.5%): May cause an allergic skin reaction [Warning Sensitization, Skin]; H319 (28.4%): Causes serious eye irritation [Warning Serious eye damage/eye irritation]; H334 (83.1%): May cause allergy or asthma symptoms or breathing difficulties if inhaled [Danger Sensitization, respiratory] 출처: European Chemicals Agency (ECHA)
- Precautionary Statement Codes: P233, P260, P261, P264, P264+P265, P270, P271, P272, P280, P284, P301+P317, P302+P352, P304+P340, P305+P351+P338, P321, P330, P332+P317, P333+P317, P337+P317, P342+P316, P362+P364, P403, and P501 (click each P-code to see the statement) 출처: European Chemicals Agency (ECHA)
- ECHA C&L Notifications Summary: Aggregated GHS information provided per 201 reports by companies from 10 notifications to the ECHA C&L Inventory. Each notification may be associated with multiple companies.; Information may vary between notifications depending on impurities, additives, and other factors. The percentage value in parenthesis indicates the notified classification ratio from companies that provide hazard codes. Only hazard codes with percentage values above 10% are shown. For more detailed information, please visit ECHA C&L website. 출처: European Chemicals Agency (ECHA)
- Signal: Warning 출처: Hazardous Chemical Information System (HCIS), Safe Work Australia
- GHS Hazard Statements: H302: Harmful if swallowed [Warning Acute toxicity, oral]; H317: May cause an allergic skin reaction [Warning Sensitization, Skin] 출처: Hazardous Chemical Information System (HCIS), Safe Work Australia
- Precautionary Statement Codes: P261, P264, P270, P272, P280, P301+P317, P302+P352, P321, P330, P333+P317, P362+P364, and P501 (click each P-code to see the statement) 출처: Hazardous Chemical Information System (HCIS), Safe Work Australia
- Signal: Danger 출처: Hazardous Substances Data Bank (HSDB)
- GHS Hazard Statements: H315: Causes skin irritation [Warning Skin corrosion/irritation]; H317: May cause an allergic skin reaction [Warning Sensitization, Skin]; H319: Causes serious eye irritation [Warning Serious eye damage/eye irritation]; H334: May cause allergy or asthma symptoms or breathing difficulties if inhaled [Danger Sensitization, respiratory] 출처: Hazardous Substances Data Bank (HSDB)
- Precautionary Statement Codes: P233, P260, P261, P264, P264+P265, P271, P272, P280, P284, P302+P352, P304+P340, P305+P351+P338, P321, P332+P317, P333+P317, P337+P317, P342+P316, P362+P364, P403, and P501 (click each P-code to see the statement) 출처: Hazardous Substances Data Bank (HSDB)
- Health Effects: It is usual for quinine in therapeutic doses to cause cinchonism; in rare cases, it may even cause death (usually by pulmonary edema). Quinine can worsen hemoglobinuria, myasthenia gravis and optic neuritis. It can cause paralysis if accidentally injected into a nerve, and is extremely toxic in overdose[Wikipedia] 출처: Toxin and Toxin Target Database (T3DB)
- Toxicity Summary: IDENTIFICATION AND USE: Quinine is a bulky, white, amorphous powder or crystalline alkaloid, used as medication: non-narcotic analgesics; antimalarial; central muscle relaxants. It is also used as flavor in carbonated beverages. HUMAN EXPOSURE AND TOXICITY: Serious hypersensitivity reactions, including anaphylactic shock, anaphylactoid reactions, urticaria, serious skin rashes, angioedema, facial edema, bronchospasm, and pruritus, have been reported with quinine. In addition, thrombocytopenia, hemolytic uremic syndrome/thrombotic thrombocytopenic purpura (HUS/TTP), immune thrombocytopenic purpura, blackwater fever, disseminated intravascular coagulation, leukopenia, neutropenia, granulomatous hepatitis, and acute interstitial nephritis have been reported and may also be due to hypersensitivity reactions to the drug. Potentially fatal cardiac arrhythmias, including torsades de pointes and ventricular fibrillation, have been reported rarely during quinine therapy. At least 1 case of fatal ventricular arrhythmia has been reported in a geriatric patient with preexisting prolonged QT interval treated with IV quinine sulfate for Plasmodium falciparum malaria. Visual impairment can range 출처: Hazardous Substances Data Bank (HSDB)
- Toxicity Summary: The theorized mechanism of action for quinine and related anti-malarial drugs is that these drugs are toxic to the malaria parasite. Specifically, the drugs interfere with the parasite's ability to break down and digest hemoglobin. Consequently, the parasite starves and/or builds up toxic levels of partially degraded hemoglobin in itself. 출처: Toxin and Toxin Target Database (T3DB)
- Uses: Medicine (antimalarial) as the alkaloid or as numerous salts and derivatives; flavoring in carbonated beverages 출처: Hazardous Substances Data Bank (HSDB)
- Uses: Flavor in carbonated beverages. 출처: Hazardous Substances Data Bank (HSDB)
- Uses: MEDICATION 출처: Hazardous Substances Data Bank (HSDB)
- Uses: MEDICATION (VET) 출처: Hazardous Substances Data Bank (HSDB)
- Uses: For more Uses (Complete) data for QUININE (8 total), please visit the HSDB record page. 출처: Hazardous Substances Data Bank (HSDB)
- Uses: Use (kg; approx.) in Germany (2009): >5000; Use (kg) in USA (2002): 56800; Consumption (g per capita; approx.) in Germany (2009): 0.0611; Consumption (g per capita) in the USA (2002): 0.201; Calculated removal (%): 41.8 출처: NORMAN Suspect List Exchange
- Uses: For the treatment of malaria and leg cramps. Used as an antipyretic (fever-reducing), antimalarial, analgesic (painkilling), and anti-inflammatory. It is also used as a flavor component of tonic water and bitter lemon. 출처: Toxin and Toxin Target Database (T3DB)
매핑 기준: Existing checksum-valid CAS to unique PubChem CID match. 가져온 시각: 2026-08-31. 출처 기록 열기
과학적 분류와 유해성 주석은 맥락을 제공할 뿐이며, 위에 표시된 시장별 규제 판단을 대체하지 않습니다.
추가 출처 적용 범위 및 일치 상태
| 출처 | 결과 | 확인됨 |
|---|---|---|
| NIH PubChem PUG-View | 정확히 일치 | 2026-08-31 |
기록된 불일치는 출처를 확인했다는 유용한 근거이며, 해당 물질이 다른 곳에 존재하지 않는다는 주장이 아닙니다.
체크섬이 유효한 CAS 일치를 통해 2026-08-31에 NIH PubChem에서 가져왔습니다. 화학적 특성은 이 페이지의 규제 판단을 대체하지 않습니다.
공식 출처 및 출처 정보
- 등록된 출처
- Australia Poisons Standard (SUSMP)
- 출처 참조
- Therapeutic Goods (Poisons Standard—June 2026) Instrument 2026, Schedule 6
- 출처 기록 ID
schedule-6:quinine:64- 출처 버전
- Therapeutic Goods (Poisons Standard—June 2026) Instrument 2026
- 출처 언어
- English
- 번역 상태
- Original is English
- 시행일
- 2026-06-01
- 출처 업데이트
- 2026-05-28
- 스냅샷 확인
- 2026-08-31 15:26 UTC
- 검증 방법
- pdftotext -layout; 674 pages; exact cosmetic-relevant per-schedule counts {2: 4, 4: 12, 5: 15, 6: 62, 10: 32}
- SHA-256
38478bdefd4ebaf571ac39001e2ce35026a7edafbaec995e75746ce69a650e11
등록된 데이터세트 주석
- 데이터세트 적용 범위
- All current Poisons Standard entries whose source wording explicitly covers cosmetics or personal-care uses
- 권위 관련 주석
- Binding Commonwealth scheduling instrument; state and territory implementation and AICIS duties still apply
이 기록이 시장 데이터세트에서 차지하는 위치
상태 분포
현재 기록 125건 중 125건에 조건 텍스트가 있습니다. 조건 필드가 비어 있는 경우 위의 기록 유형에 따라 해석되며, 제한 없는 사용에 대한 주장으로 전환되지 않습니다.
Australia 시장 맥락
Complete cosmetic-relevant Poisons Standard subset plus official workflow
적용 범위 버전: Therapeutic Goods (Poisons Standard—June 2026) Instrument 2026
All 125 current Schedule 2, 4, 5, 6 and 10 entries whose legal wording explicitly covers cosmetics or personal-care uses, plus AICIS verification links.
확인 체크리스트
- Decide whether the product is a cosmetic or therapeutic good.
- Check the current Poisons Standard for every ingredient.
- Search AICIS Inventory terms and assessment certificates by exact identity.
- Determine introduction category, registration, reporting, records and labelling duties.
공식 시장 출처
- Australia AICIS InventoryNot an allowed/banned cosmetics list; use for per-CAS enrichment and source links
- Australia Poisons Standard (SUSMP)Binding Commonwealth scheduling instrument; state and territory implementation and AICIS duties still apply
- Australia AICIS banned or restricted chemicals guidanceWorkflow guidance, not an exhaustive ingredient list
확인 절차 및 기록 완전성
이 결과를 규제 준수 판단에 사용하기 전에
- “QUININE”와(과) 모든 CAS/EC 식별자가 공급업체 규격서의 물질을 가리키는지 확인하세요.
- Decide whether the product is a cosmetic or therapeutic good.
- Check the current Poisons Standard for every ingredient.
- Search AICIS Inventory terms and assessment certificates by exact identity.
- Determine introduction category, registration, reporting, records and labelling duties.
- 출처 버전을 기록하고, 제조, 신고 또는 시장 출시 전에 규제 기관을 다시 확인하세요.
이 기록에서 제공되는 필드
- 공식 물질 명칭제공됨
- CAS제공됨
- EC제공됨
- 별도의 조건 텍스트제공됨
- 시행일제공됨
- 스냅샷 해시 및 방법제공됨
이 페이지가 답하는 질문
안정적인 인용
QUININE. Therapeutic Goods (Poisons Standard—June 2026) Instrument 2026, Schedule 6. Australia. Source version Therapeutic Goods (Poisons Standard—June 2026) Instrument 2026. CosIng Checker regulatory record: https://cosingchecker.com/ko/regulations/au/records/13170/
법적 권위로서 규제 기관을 인용하세요. 이 페이지는 구조화된 근거 색인이자 확인 보조 도구이며, 공식 본문이나 전문적인 법률 평가를 대체하지 않습니다.
Australia의 해석 및 한계
This substance is not unrestricted: cosmetic use is subject to the conditions in the cited official record.
Check product type, body area, concentration, purity and warning requirements before deciding whether a formulation is compliant.
법적 역할 해석 방법
The cited row forms part of a binding rule or legally incorporated list for this market.
이 페이지의 근거
- 기록된 결과: Restricted
- 법적 역할: Binding rule
- 출처 버전: Therapeutic Goods (Poisons Standard—June 2026) Instrument 2026
- 시행일: 2026-06-01
증명하지 않는 것
An AICIS Inventory match is not cosmetic approval; no Inventory match can indicate a new, exempted, reported or confidential introduction.
추가 공신력 있는 물질 조사
이 출처들 중 어느 것도 위의 시장 판단을 번복하지 않습니다.
Cosmetic Ingredient Review safety assessments
Expert Panel conclusions, assessed ingredient groups, use conditions, dates and report documents
Independent expert review considered by FDA; not a government approval or binding market rule
출처에서 이 정체 조사FDA Global Substance Registration System
UNII identifiers, preferred names, substance types, codes and public substance relationships
Identity registry only; UNII availability does not imply FDA review or approval
출처에서 이 정체 조사ILO/WHO International Chemical Safety Cards
Hazards, symptoms, first aid, storage, incompatibilities and physical properties for covered chemicals
International occupational chemical-safety reference; not cosmetic-use approval
출처에서 이 정체 조사Japan NITE-CHRIP
Chemical identity, Japanese and foreign legal lists, GHS hazards and exposure-related information
Chemical-management evidence; cosmetic status remains governed by the applicable MHLW standard and market rules
출처에서 이 정체 조사NIOSH Pocket Guide to Chemical Hazards
REL, PEL, IDLH, properties, exposure routes, symptoms, target organs, first aid and measurement methods for covered workplace chemicals
US occupational-health guidance and limits; not a cosmetic ingredient decision
출처에서 이 정체 조사OECD eChemPortal
Gateway to authority-owned physical-property, fate, ecotoxicity, toxicity, exposure and GHS records
Discovery gateway; each linked authority remains responsible for its data
출처에서 이 정체 조사US EPA CompTox CTX APIs
가져오기에 API 키 필요DTXSID identity, experimental and predicted properties, toxicity, bioactivity, exposure and environmental data
Scientific and computational evidence; predictions must remain labelled and do not determine cosmetic legality
출처에서 이 정체 조사